Explore the words cloud of the PIPPI project. It provides you a very rough idea of what is the project "PIPPI" about.
The following table provides information about the project.
Coordinator |
DANMARKS TEKNISKE UNIVERSITET
Organization address contact info |
Coordinator Country | Denmark [DK] |
Project website | http://www.pippi.kemi.dtu.dk/ |
Total cost | 4˙067˙745 € |
EC max contribution | 4˙067˙745 € (100%) |
Programme |
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers) |
Code Call | H2020-MSCA-ITN-2015 |
Funding Scheme | MSCA-ITN-ETN |
Starting year | 2016 |
Duration (year-month-day) | from 2016-01-01 to 2019-12-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | DANMARKS TEKNISKE UNIVERSITET | DK (KGS LYNGBY) | coordinator | 580˙163.00 |
2 | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN | DE (MUENCHEN) | participant | 747˙649.00 |
3 | NOVOZYMES A/S | DK (BAGSVAERD) | participant | 580˙163.00 |
4 | MEDIMMUNE LIMITED | UK (CAMBRIDGE) | participant | 546˙575.00 |
5 | THE UNIVERSITY OF MANCHESTER | UK (MANCHESTER) | participant | 546˙575.00 |
6 | LUNDS UNIVERSITET | SE (LUND) | participant | 527˙318.00 |
7 | KOBENHAVNS UNIVERSITET | DK (KOBENHAVN) | participant | 290˙081.00 |
8 | WYATT TECHNOLOGY EUROPE GMBH | DE (Dernbach) | participant | 249˙216.00 |
9 | LUNDS UNIVERSITET | SE (Lund) | partner | 0.00 |
10 | NANOTEMPER TECHNOLOGIES GMBH | DE (MUNCHEN) | partner | 0.00 |
The revolution of biotechnology has led to the creation of various types of therapeutic biologics with the potential to provide treatment for new chronic and malignant diseases. Though the potential advantages of biologics lay in their high specificity and potency combined with few side effects, their formulation still remains a large challenge to pharmaceutical scientists. This is in part due to the complex, not-well understood relationship between the physicochemical properties of proteins and formulation conditions required for protein stability. A comprehensive understanding of the molecular mechanisms behind protein stabilization and solubility would provide the formulation scientists with knowledge of the interplay between formulation and stability that in turn could potentially make formulation development faster, cheaper and less labour intensive than the currently used broad screening approach. Understanding the susceptibilities of formulations to protein aggregation and denaturation can reduce the response time to for instance product failure. Few universities in Europe have formulation of biologics as a scientific subject. Consequently, the pharmaceutical industry is forced to train scientists - a challenge for larger companies, and an insurmountable task for smaller companies. Scientists in the field of structural biology, biophysics, protein formulation and stability have formed a consortium to systematically map physicochemical properties of biologics, formulation conditions and protein stability. The main objective of the consortium is to provide a new generation of innovative and entrepreneurial early-stage researchers that will develop methodologies, tools and databases to guide the formulation of robust biologics. The consortium will not only provide an excellent platform to train a new generation of formulation scientists, but also establish avenues for designing new formulation strategies and thereby securing the leading edge of EU expertise.
Project website | Websites, patent fillings, videos etc. | 2019-05-31 18:15:21 |
Take a look to the deliverables list in detail: detailed list of PIPPI deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2019 |
Priyanka Singh, Aisling Roche, Christopher F. van der Walle, Shahid Uddin, Jiali Du, Jim Warwicker, Alain Pluen, Robin Curtis Determination of Protein–Protein Interactions in a Mixture of Two Monoclonal Antibodies published pages: 4775-4786, ISSN: 1543-8384, DOI: 10.1021/acs.molpharmaceut.9b00430 |
Molecular Pharmaceutics 16/12 | 2020-02-13 |
2019 |
Max Hebditch, Aisling Roche, Robin A. Curtis, Jim Warwicker Models for Antibody Behavior in Hydrophobic Interaction Chromatography and in Self-Association published pages: 1434-1441, ISSN: 0022-3549, DOI: 10.1016/j.xphs.2018.11.035 |
Journal of Pharmaceutical Sciences 108/4 | 2020-01-30 |
2019 |
Matja Zalar, Alexander P. Golovanov New Disulphide Bond in Cystatin-Based Protein Scaffold Prevents Domain-Swap-Mediated Oligomerization and Stabilizes the Functionally Active Form published pages: 18248-18256, ISSN: 2470-1343, DOI: 10.1021/acsomega.9b02269 |
ACS Omega 4/19 | 2020-01-30 |
2019 |
Lorenzo Gentiluomo, Dierk Roessner, Dillen Augustijn, Hristo Svilenov, Alina Kulakova, Sujata Mahapatra, Gerhard Winter, Werner Streicher, Åsmund Rinnan, Günther H.J. Peters, Pernille Harris, Wolfgang Frieß Application of interpretable artificial neural networks to early monoclonal antibodies development published pages: 81-89, ISSN: 0939-6411, DOI: 10.1016/j.ejpb.2019.05.017 |
European Journal of Pharmaceutics and Biopharmaceutics 141 | 2020-01-30 |
2019 |
Hristo Svilenov, Gerhard Winter Rapid sample-saving biophysical characterisation and long-term storage stability of liquid interferon alpha2a formulations: Is there a correlation? published pages: 42-50, ISSN: 0378-5173, DOI: 10.1016/j.ijpharm.2019.03.025 |
International Journal of Pharmaceutics 562 | 2020-01-30 |
2019 |
A. Kulakova, S. Indrakumar, P. Sønderby, L. Gentiluomo, W. Streicher, D. Roessner, W. Frieß, G. H.J.
Peters, P. Harris Structural-stability studies on recombinant human transferrin published pages: , ISSN: , DOI: 10.1101/742957 |
bioRxiv | 2020-01-30 |
2020 |
Andreas Tosstorff, Tim Menzen, Gerhard Winter Exploring Chemical Space for New Substances to Stabilize a Therapeutic Monoclonal Antibody published pages: 301-307, ISSN: 0022-3549, DOI: 10.1016/j.xphs.2019.10.057 |
Journal of Pharmaceutical Sciences 109/1 | 2020-01-30 |
2020 |
Alina Kulakova, Sowmya Indrakumar, Pernille Sønderby, Lorenzo Gentiluomo, Werner Streicher, Dierk Roessner, Wolfgang Frieß, Günther H.J. Peters, Pernille Harris Small angle X-ray scattering and molecular dynamic simulations provide molecular insight for stability of recombinant human transferrin published pages: 100017, ISSN: 2590-1524, DOI: 10.1016/j.yjsbx.2019.100017 |
Journal of Structural Biology: X 4 | 2020-01-30 |
2018 |
Roberto Fernandez-Alvarez, Žiga MedoÅ¡, ZdenÄ›k ToÅ¡ner, Alexander Zhigunov, Mariusz Uchman, Stefan Hervø-Hansen, Mikael Lund, Marija BeÅ¡ter-RogaÄ, Pavel MatÄ›jÃÄek Total Description of Intrinsic Amphiphile Aggregation: Calorimetry Study and Molecular Probing published pages: 14448-14457, ISSN: 0743-7463, DOI: 10.1021/acs.langmuir.8b03462 |
Langmuir 34/47 | 2020-01-30 |
2020 |
Lorenzo Gentiluomo, Dierk Roessner, Werner Streicher, Sujata Mahapatra, Pernille Harris, Wolfgang Frieß Characterization of Native Reversible Self-Association of a Monoclonal Antibody Mediated by Fab-Fab Interaction published pages: 443-451, ISSN: 0022-3549, DOI: 10.1016/j.xphs.2019.09.021 |
Journal of Pharmaceutical Sciences 109/1 | 2020-01-30 |
2019 |
Andreas Tosstorff, Hristo Svilenov, Günther H.J. Peters, Pernille Harris, Gerhard Winter Structure-based discovery of a new protein-aggregation breaking excipient published pages: 207-216, ISSN: 0939-6411, DOI: 10.1016/j.ejpb.2019.09.010 |
European Journal of Pharmaceutics and Biopharmaceutics 144 | 2020-01-30 |
2019 |
Marcello Martinez Morales, Matja Zalar, Silvia Sonzini, Alexander P. Golovanov, Christopher F. van der Walle, Jeremy P. Derrick Interaction of a Macrocycle with an Aggregation-Prone Region of a Monoclonal Antibody published pages: 3100-3108, ISSN: 1543-8384, DOI: 10.1021/acs.molpharmaceut.9b00338 |
Molecular Pharmaceutics 16/7 | 2020-01-30 |
2020 |
Lorenzo Gentiluomo, Hristo L. Svilenov, Dillen Augustijn, Inas El Bialy, Maria Laura Greco, Alina Kulakova, Sowmya Indrakumar, Sujata Mahapatra, Marcello Martinez Morales, Christin Pohl, Aisling Roche, Andreas Tosstorff, Robin Curtis, Jeremy P. Derrick, Allan Nørgaard, Tarik A. Khan, Günther H. J. Peters, Alain Pluen, Åsmund Rinnan, Werner W. Streicher, Christopher F. van der Walle, Shahid Uddi Advancing Therapeutic Protein Discovery and Development through Comprehensive Computational and Biophysical Characterization published pages: , ISSN: 1543-8384, DOI: 10.1021/acs.molpharmaceut.9b00852 |
Molecular Pharmaceutics | 2020-01-30 |
2019 |
Dillen Augustijn, Sujata Mahapatra, Werner Streicher, Hristo Svilenov, Alina Kulakova, Christin Pohl, Ã…smund Rinnan Novel non-linear curve fitting to resolve protein unfolding transitions in intrinsic fluorescence differential scanning fluorimetry published pages: 506-517, ISSN: 0939-6411, DOI: 10.1016/j.ejpb.2019.06.001 |
European Journal of Pharmaceutics and Biopharmaceutics 142 | 2020-01-30 |
2019 |
Lorenzo Gentiluomo, Vanessa Schneider, Dierk Roessner, Wolfgang Frieß Coupling Multi-Angle Light Scattering to Reverse-Phase Ultra-High-Pressure Chromatography (RP-UPLC-MALS) for the characterization monoclonal antibodies published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-019-51233-6 |
Scientific Reports 9/1 | 2020-01-30 |
2019 |
Matja Zalar, Sowmya Indrakumar, Colin W. Levy, Richard B. Tunnicliffe, Günther H. J. Peters, Alexander P. Golovanov Studies of the oligomerisation mechanism of a cystatin-based engineered protein scaffold published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-019-45565-6 |
Scientific Reports 9/1 | 2020-01-30 |
2020 |
Hristo L. Svilenov, Alina Kulakova, Matja Zalar, Alexander P. Golovanov, Pernille Harris, Gerhard Winter Orthogonal Techniques to Study the Effect of pH, Sucrose, and Arginine Salts on Monoclonal Antibody Physical Stability and Aggregation During Long-Term Storage published pages: 584-594, ISSN: 0022-3549, DOI: 10.1016/j.xphs.2019.10.065 |
Journal of Pharmaceutical Sciences 109/1 | 2020-01-30 |
2019 |
Silvia Sonzini, Maria Laura Greco, Thais Cailleau, Lauren Adams, Luke Masterson, Balakumar Vijayakrishnan, Conor Barry, Phillip Howard, Peter Ravn, Christopher F. van der Walle Improved Physical Stability of an Antibody–Drug Conjugate Using Host–Guest Chemistry published pages: , ISSN: 1043-1802, DOI: 10.1021/acs.bioconjchem.9b00809 |
Bioconjugate Chemistry | 2020-01-30 |
2019 |
Sowmya Indrakumar, Matja Zalar, Christin Pohl, Allan Nørgaard, Werner Streicher, Pernille Harris, Alexander P. Golovanov, Günther H.J. Peters Conformational Stability Study of a Therapeutic Peptide Plectasin Using Molecular Dynamics Simulations in Combination with NMR published pages: 4867-4877, ISSN: 1520-6106, DOI: 10.1021/acs.jpcb.9b02370 |
The Journal of Physical Chemistry B 123/23 | 2020-01-30 |
2019 |
Hristo Svilenov, Gerhard Winter The ReFOLD assay for protein formulation studies and prediction of protein aggregation during long-term storage published pages: 131-139, ISSN: 0939-6411, DOI: 10.1016/j.ejpb.2019.02.018 |
European Journal of Pharmaceutics and Biopharmaceutics 137 | 2020-01-30 |
2017 |
Pernille Harris PIPPI – Protein-excipient Interactions and Protein-Protein Interactions in formulation – ERC published pages: 75-77, ISSN: 2398-7073, DOI: 10.21820/23987073.2017.8.75 |
Impact 2017/8 | 2019-07-08 |
2018 |
Hristo Svilenov, Lorenzo Gentiluomo, Wolfgang Friess, Dierk Roessner, Gerhard Winter A New Approach to Study the Physical Stability of Monoclonal Antibody Formulations—Dilution From a Denaturant published pages: 3007-3013, ISSN: 0022-3549, DOI: 10.1016/j.xphs.2018.08.004 |
Journal of Pharmaceutical Sciences 107/12 | 2019-02-26 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PIPPI" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PIPPI" are provided by the European Opendata Portal: CORDIS opendata.